NCT03429920View on ClinicalTrials.gov

Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 23, 2018

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Cardiovascular Risk FactorHeart DiseasesInflammation
Interventions
DIETARY_SUPPLEMENT

Q CAN PLUS

Active powder with fermented soy , 2 pouches per day, each pouch contains 12-15 gms of fermented soy

DIETARY_SUPPLEMENT

Placebo

Sprouted brown rice protein with flavor (provided by BESO Biological Research, Inc.)

Trial Locations (1)

92350

Loma Linda University, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER

NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors | Biotech Hunter | Biotech Hunter